Barr Pharmaceuticals is being joined by medical, legislative and women's groups to make the morning-after Plan B contraceptive available to teens 17 and younger without a prescription. Those on both sides of last week's FDA decision say they plan legal or legislative efforts either to widen the OTC availability or strike down the FDA "dual-status" sales policy.

Related Summaries